The future of longevity: investing in the next biotech revolution
The Motley Fool - 13-Aug-2024How lifespan-extending drugs could shape the next biotech boom
Join the club for FREE to access the whole archive and other member benefits.
Alex Carchidi is a writer, consultant, entrepreneur, and contributor to The Motley Fool
Alex Carchidi is a writer, consultant, and entrepreneur with contributions to The Motley Fool. Since early 2020, Alex has been writing for The Motley Fool, specializing in healthcare companies. With a background in biotech research, he brings his scientific expertise to his writing and entrepreneurial ventures. Outside of work, Alex enjoys exploring Boston, traveling throughout Latin America, and engaging in value investing.
Visit website: https://www.fool.com/author/20287/
See alsoDetails last updated 23-Aug-2024
How lifespan-extending drugs could shape the next biotech boom